ProUroCare Medical Inc.
PUMD
$0.00
$0.000.00%
OTC PK
| 09/30/2013 | 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.25% | -22.19% | -16.32% | -18.25% | -12.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -76.94% | -79.74% | -17.58% | -20.19% | 33.96% |
| Operating Income | 76.94% | 79.74% | 17.58% | 20.19% | -33.96% |
| Income Before Tax | 26.07% | 24.96% | -55.58% | -43.42% | -42.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.07% | 24.96% | -55.58% | -43.42% | -42.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.07% | 24.96% | -55.58% | -43.42% | -42.28% |
| EBIT | 76.94% | 79.74% | 17.58% | 20.19% | -33.96% |
| EBITDA | 77.08% | 79.83% | 17.64% | 20.20% | -33.98% |
| EPS Basic | 30.78% | 30.33% | -43.71% | -33.23% | -33.63% |
| Normalized Basic EPS | 66.79% | 71.09% | 13.89% | 15.99% | -33.72% |
| EPS Diluted | 30.78% | 30.33% | -43.71% | -33.23% | -33.63% |
| Normalized Diluted EPS | 66.79% | 71.09% | 13.89% | 15.99% | -33.72% |
| Average Basic Shares Outstanding | 7.60% | 9.05% | 9.23% | 7.54% | 5.88% |
| Average Diluted Shares Outstanding | 7.60% | 9.05% | 9.23% | 7.54% | 5.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |